Genomics In Cancer Care Market Report 2023

Genomics In Cancer Care Global Market Report 2025 – By Product Type( Instruments, Consumables, Services), By Technology( PCR (?Polymerase Chain Reaction), MicroArrays, Genome Sequencing, Other Technologies), By Application( Diagnostics, Personalized Medicine, Drug Discovery And Development, Research), By End-user( Hospitals, Government Institutes, Research Facilities) – Market Size, Trends, And Global Forecast 2025-2034

Genomics In Cancer Care Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Genomics In Cancer Care Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Genomics In Cancer Care Market Definition

Genomics in cancer care refers to the examination of all variations in DNA sequence and gene expression between tumor cells and healthy host cells to recognize the patients' genetic backgrounds to provide better cancer treatment. Genomics in cancer care is used to detect cancer-causing mutations, enhance tumor-specific diagnostic techniques and treatment plans, enable precision medicine research and drug development, and allow the development of targeted therapies to offer personalized medicines to patients suffering from various types of cancers.

The main product types of genomics in cancer care are instruments, consumables, and services. Instruments refer to devices or equipment used for the detection of tumors in cancer genomics. Instruments are used to provide accurate diagnostics in cancer genomics. The technology used are PCR, microarrays, genome sequencing and others. The applications of genomics in cancer care are diagnostics, personalized medicine, drug discovery and development, and research that are used by hospitals, government institutes, and research facilities.

Genomics In Cancer Care Market Segmentation

The genomics in cancer care market covered in this report is segmented –

1) By Product Type: Instruments, Consumables, Services

2) By Technology: PCR (?Polymerase Chain Reaction), MicroArrays, Genome Sequencing, Other Technologies

3) By Application: Diagnostics, Personalized Medicine, Drug Discovery And Development, Research

4) By End-User: Hospitals, Government Institutes, Research Facilities

Subsegments:

1) By Instruments: Sequencers, PCR Machines, Microarrays, Other Diagnostic Instruments

2) By Consumables: Reagents And Kits, Sample Preparation Products, Nucleotides, Other Consumables

3) By Services: Data Analysis Services, Bioinformatics Services, Genetic Testing Services, Other Support Services

Genomics In Cancer Care Market Size and growth rate 2025 to 2029: Graph

Genomics In Cancer Care Market Size 2025 And Growth Rate

The genomics in cancer care market size has grown rapidly in recent years. It will grow from $17.6 billion in 2024 to $20.73 billion in 2025 at a compound annual growth rate (CAGR) of 17.8%. The growth in the historic period can be attributed to early research and development, development of companion diagnostics, ethical and legal frameworks, data standardization and interpretation, initial market penetration.

Genomics In Cancer Care Market Growth Forecast

The genomics in cancer care market size is expected to see rapid growth in the next few years. It will grow to $38.57 billion in 2029 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to increasing prevalence of cancer, advancements in data analytics, market expansion in emerging economies, genomic data privacy and security, improving healthcare infrastructure. Major trends in the forecast period include technological advancements, personalized medicine, reduced costs of genomic sequencing, regulatory support and guidelines, patient awareness and demand.

Genomics In Cancer Care Market Driver: The Ascendance Of Genomics In Meeting The Demand For Advanced Cancer Diagnostics

Growing demand for cancer diagnostics is expected to propel genomics in the cancer care market. Cancer diagnostics refers to identifying the right tumor kind, location, extent, and stage by tests and procedures confirming the disease's presence. Genomics in cancer care helps in determining a suitable treatment plan for cancer patients by recognizing their genetic backgrounds For instance, in July 2024, according to The Cancer Research UK, a UK-based cancer research organization, The average annual number of new cancer cases in the UK is expected to increase from approximately 420,000 cases during 2023-2025 to about 506,000 cases by 2038-2040. Therefore, the growing demand for cancer diagnostics is expected to drive genomics in the cancer care market.

Genomics In Cancer Care Market Driver: Unleashing Growth Through Increased Funding And Investments In Cancer Research

Increase in funding and investments for genomics research for cancer is expected to propel the growth of the genomics in cancer care market going forward. 'Funding and investments' refer to the financial resources provided to a business, project, or initiative to support its operations, development, or expansion. The integration of genomics in cancer care has spurred significant funding and investment across the healthcare and biotechnology sectors. As the understanding of genetic factors influencing cancer continues to advance, investors are increasingly drawn to innovative companies developing cutting-edge genomics technologies. These technologies range from next-generation sequencing platforms for comprehensive genomic profiling to liquid biopsy assays that enable non-invasive monitoring of cancer progression. For instance, in December 2022, according to an article published by the gov.uk, a UK-based public sector information website, the UK government has invested around £175 million ($1.2 million) to boost the cutting-edge genomics research. The funding will enable research which could deliver world-leading genomic healthcare to patients. Therefore, an increase in funding and investments for genomics research for cancer is driving the genomics in cancer care market.

Global Genomics In Cancer Care Market Major Players

Major companies operating in the genomics in cancer care market are Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Danaher Corporation, Pacific Biosciences of California Inc., Roche Holding AG, Quest Diagnostics Incorporated, DiaSorin S.p.A., BGI Group, Myriad Genetics Inc., NeoGenomics Laboratories, Foundation Medicine Inc., Intermountain Healthcare, Laboratory Corporation of America Holdings, Flatiron Health Inc., Personal Genome Diagnostics Inc., Natera Inc., GRAIL Inc., Freenome Holdings Inc., Caris Life Sciences Inc., Tempus Labs Inc., OncoDNA S.A., Biocept Inc., GenomOncology Corp., OncoCyte Corporation, PathAI Inc., Enzyme Corporation, Karius Inc., N-of-One Inc., Oncora Medical Inc., Paradigm Diagnostics Inc., PierianDx Inc., Predicine Inc., Resolution Bioscience Inc., Strata Oncology Inc.

Global Genomics In Cancer Care Market Trend: Transforming Cancer Care The Rise Of Robotic Genomic Testing Facilitie

Major companies operating in the genomics in cancer care market are focused on introducing robotic genomic testing facilities to enhance the accuracy and efficiency of genetic testing, reduce turnaround times, and improve patient outcomes by enabling personalized treatment strategies based on individual genetic profiles. Robotic genomic testing facilities refer to advanced laboratory environments equipped with automated systems and robotic technologies designed to perform various genomic analyses. Utilizing Automata’s LINQ platform, the lab incorporates six robotic arms that automate sample preparation for various types of biological materials, including saliva, blood, bone marrow, and tissue biopsies. For instance, in September 2024, The Royal Marsden NHS Foundation Trust, a UK-based cancer hospital, launched robotic genomic testing facility aimed at enhancing cancer diagnosis and treatment. The facility will double the genomic testing capacity of the Royal Marsden, allowing for a greater volume of tests to be processed without compromising accuracy.

Global Genomics In Cancer Care Market Trend: C2I Genomics And Karkinos Healthcare Forge Strategic Partnership

Major companies collaborate and get into partnerships to strengthen their position in the genomics in cancer care market. A business strategic partnership refers to a structured affiliation between two or more commercial enterprises, typically established via one or more business agreements or contracts. For instance, in June 2022, C2i Genomics, an Israel-based genomic cancer treatments company partnered with Karkinos Healthcare. The collaboration seeks to bring innovative cancer detection technology to drive R&D, future pharma partnerships and clinical use in India and supports the C2i Genomic’s long-term goals to scale pharma R&D projects around the globe. Karkinos Healthcare is an India-based technology LED managed care platform for cancer.

Genomics In Cancer Care Market Merger And Acquisition: Seagen Acquisition Pfizer's Commitment To Advancing Genomic Cancer Solutions

In December 2023, Pfizer Inc., a US-based company, acquired Seagen Inc. for $43 billion. With this acquisition, Pfizer aims to expand its portfolio by incorporating Seagen's expertise in providing cancer care through innovative genomic approaches. Seagen Inc. is a US-based company that offers cancer care through innovative genomic approaches.

Regional Outlook For The Global Genomics In Cancer Care Market

North America was the largest region in the genomics in cancer care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics in cancer care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genomics in cancer care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Genomics In Cancer Care Market?

The genomics in the cancer care market consists of revenues earned by entities by providing sequencing to identify DNA and RNA alterations, and defining molecular subtypes. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Genomics In Cancer Care Industry?

The genomics in cancer care market research report is one of a series of new reports from The Business Research Company that provides genomics in cancer care market statistics, including genomics in cancer care industry global market size, regional shares, competitors with a genomics in cancer care market share, detailed genomics in cancer care market segments, market trends and opportunities, and any further data you may need to thrive in the genomics in cancer care industry. This genomics in cancer care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Genomics In Cancer Care Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $20.73 billion
Revenue Forecast In 2034 $38.57 billion
Growth Rate CAGR of 16.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product Type: Instruments, Consumables, Services
2) By Technology: PCR (?Polymerase Chain Reaction), MicroArrays, Genome Sequencing, Other Technologies
3) By Application: Diagnostics, Personalized Medicine, Drug Discovery And Development, Research
4) By End-User: Hospitals, Government Institutes, Research Facilities Subsegments: 1) By Instruments: Sequencers, PCR Machines, Microarrays, Other Diagnostic Instruments
2) By Consumables: Reagents And Kits, Sample Preparation Products, Nucleotides, Other Consumables
3) By Services: Data Analysis Services, Bioinformatics Services, Genetic Testing Services, Other Support Services
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Danaher Corporation, Pacific Biosciences of California Inc., Roche Holding AG, Quest Diagnostics Incorporated, DiaSorin S.p.A., BGI Group, Myriad Genetics Inc., NeoGenomics Laboratories, Foundation Medicine Inc., Intermountain Healthcare, Laboratory Corporation of America Holdings, Flatiron Health Inc., Personal Genome Diagnostics Inc., Natera Inc., GRAIL Inc., Freenome Holdings Inc., Caris Life Sciences Inc., Tempus Labs Inc., OncoDNA S.A., Biocept Inc., GenomOncology Corp., OncoCyte Corporation, PathAI Inc., Enzyme Corporation, Karius Inc., N-of-One Inc., Oncora Medical Inc., Paradigm Diagnostics Inc., PierianDx Inc., Predicine Inc., Resolution Bioscience Inc., Strata Oncology Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Genomics In Cancer Care Market Characteristics

    3. Genomics In Cancer Care Market Trends And Strategies

    4. Genomics In Cancer Care Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Genomics In Cancer Care Growth Analysis And Strategic Analysis Framework

    5.1. Global Genomics In Cancer Care PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Genomics In Cancer Care Market Growth Rate Analysis

    5.4. Global Genomics In Cancer Care Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Genomics In Cancer Care Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Genomics In Cancer Care Total Addressable Market (TAM)

    6. Genomics In Cancer Care Market Segmentation

    6.1. Global Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Instruments

    Consumables

    Services

    6.2. Global Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    PCR (?Polymerase Chain Reaction)

    MicroArrays

    Genome Sequencing

    Other Technologies

    6.3. Global Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Diagnostics

    Personalized Medicine

    Drug Discovery And Development

    Research

    6.4. Global Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Government Institutes

    Research Facilities

    6.5. Global Genomics In Cancer Care Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Sequencers

    PCR Machines

    Microarrays

    Other Diagnostic Instruments

    6.6. Global Genomics In Cancer Care Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Reagents And Kits

    Sample Preparation Products

    Nucleotides

    Other Consumables

    6.7. Global Genomics In Cancer Care Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Data Analysis Services

    Bioinformatics Services

    Genetic Testing Services

    Other Support Services

    7. Genomics In Cancer Care Market Regional And Country Analysis

    7.1. Global Genomics In Cancer Care Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Genomics In Cancer Care Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Genomics In Cancer Care Market

    8.1. Asia-Pacific Genomics In Cancer Care Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Genomics In Cancer Care Market

    9.1. China Genomics In Cancer Care Market Overview

    9.2. China Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Genomics In Cancer Care Market

    10.1. India Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Genomics In Cancer Care Market

    11.1. Japan Genomics In Cancer Care Market Overview

    11.2. Japan Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Genomics In Cancer Care Market

    12.1. Australia Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Genomics In Cancer Care Market

    13.1. Indonesia Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Genomics In Cancer Care Market

    14.1. South Korea Genomics In Cancer Care Market Overview

    14.2. South Korea Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Genomics In Cancer Care Market

    15.1. Western Europe Genomics In Cancer Care Market Overview

    15.2. Western Europe Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Genomics In Cancer Care Market

    16.1. UK Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Genomics In Cancer Care Market

    17.1. Germany Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Genomics In Cancer Care Market

    18.1. France Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Genomics In Cancer Care Market

    19.1. Italy Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Genomics In Cancer Care Market

    20.1. Spain Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Genomics In Cancer Care Market

    21.1. Eastern Europe Genomics In Cancer Care Market Overview

    21.2. Eastern Europe Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Genomics In Cancer Care Market

    22.1. Russia Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Genomics In Cancer Care Market

    23.1. North America Genomics In Cancer Care Market Overview

    23.2. North America Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Genomics In Cancer Care Market

    24.1. USA Genomics In Cancer Care Market Overview

    24.2. USA Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Genomics In Cancer Care Market

    25.1. Canada Genomics In Cancer Care Market Overview

    25.2. Canada Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Genomics In Cancer Care Market

    26.1. South America Genomics In Cancer Care Market Overview

    26.2. South America Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Genomics In Cancer Care Market

    27.1. Brazil Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Genomics In Cancer Care Market

    28.1. Middle East Genomics In Cancer Care Market Overview

    28.2. Middle East Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Genomics In Cancer Care Market

    29.1. Africa Genomics In Cancer Care Market Overview

    29.2. Africa Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Genomics In Cancer Care Market Competitive Landscape And Company Profiles

    30.1. Genomics In Cancer Care Market Competitive Landscape

    30.2. Genomics In Cancer Care Market Company Profiles

    30.2.1. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. QIAGEN N.V. Overview, Products and Services, Strategy and Financial Analysis

    31. Genomics In Cancer Care Market Other Major And Innovative Companies

    31.1. Bio-Rad Laboratories Inc.

    31.2. Danaher Corporation

    31.3. Pacific Biosciences of California Inc.

    31.4. Roche Holding AG

    31.5. Quest Diagnostics Incorporated

    31.6. DiaSorin S.p.A.

    31.7. BGI Group

    31.8. Myriad Genetics Inc.

    31.9. NeoGenomics Laboratories

    31.10. Foundation Medicine Inc.

    31.11. Intermountain Healthcare

    31.12. Laboratory Corporation of America Holdings

    31.13. Flatiron Health Inc.

    31.14. Personal Genome Diagnostics Inc.

    31.15. Natera Inc.

    32. Global Genomics In Cancer Care Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Genomics In Cancer Care Market

    34. Recent Developments In The Genomics In Cancer Care Market

    35. Genomics In Cancer Care Market High Potential Countries, Segments and Strategies

    35.1 Genomics In Cancer Care Market In 2029 - Countries Offering Most New Opportunities

    35.2 Genomics In Cancer Care Market In 2029 - Segments Offering Most New Opportunities

    35.3 Genomics In Cancer Care Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Genomics In Cancer Care Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Genomics In Cancer Care Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Genomics In Cancer Care Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Genomics In Cancer Care Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Genomics In Cancer Care Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Illumina Inc. Financial Performance
  • Table 79: Thermo Fisher Scientific Inc. Financial Performance
  • Table 80: Agilent Technologies Inc. Financial Performance
  • Table 81: PerkinElmer Inc. Financial Performance
  • Table 82: QIAGEN N.V. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Genomics In Cancer Care Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Genomics In Cancer Care Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Genomics In Cancer Care Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Genomics In Cancer Care Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Genomics In Cancer Care Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Illumina Inc. Financial Performance
  • Figure 79: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 80: Agilent Technologies Inc. Financial Performance
  • Figure 81: PerkinElmer Inc. Financial Performance
  • Figure 82: QIAGEN N.V. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the genomics in cancer care market?

Genomics in cancer care refers to the examination of all variations in DNA sequence and gene expression between tumor cells and healthy host cells to recognize the patients' genetic backgrounds to provide better cancer treatment. Genomics in cancer care is used to detect cancer-causing mutations, enhance tumor-specific diagnostic techniques and treatment plans, enable precision medicine research and drug development, and allow the development of targeted therapies to offer personalized medicines to patients suffering from various types of cancers. For further insights on the genomics in cancer care market, request a sample here

How will the genomics in cancer care market drivers and restraints affect the genomics in cancer care market dynamics? What forces will shape the genomics in cancer care industry going forward?

The genomics in cancer care market major growth driver - Genomics in cancer care refers to the examination of all variations in DNA sequence and gene expression between tumor cells and healthy host cells to recognize the patients' genetic backgrounds to provide better cancer treatment. Genomics in cancer care is used to detect cancer-causing mutations, enhance tumor-specific diagnostic techniques and treatment plans, enable precision medicine research and drug development, and allow the development of targeted therapies to offer personalized medicines to patients suffering from various types of cancers. . For further insights on the genomics in cancer care market, request a sample here

What is the forecast market size or the forecast market value of the genomics in cancer care market?

The genomics in cancer care market size has grown rapidly in recent years. It will grow from $17.6 billion in 2024 to $20.73 billion in 2025 at a compound annual growth rate (CAGR) of 17.8%. The growth in the historic period can be attributed to early research and development, development of companion diagnostics, ethical and legal frameworks, data standardization and interpretation, initial market penetration. The genomics in cancer care market size is expected to see rapid growth in the next few years. It will grow to $38.57 billion in 2029 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to increasing prevalence of cancer, advancements in data analytics, market expansion in emerging economies, genomic data privacy and security, improving healthcare infrastructure. Major trends in the forecast period include technological advancements, personalized medicine, reduced costs of genomic sequencing, regulatory support and guidelines, patient awareness and demand. For further insights on the genomics in cancer care market, request a sample here

How is the genomics in cancer care market segmented?

The genomics in cancer care market is segmented
1) By Product Type: Instruments, Consumables, Services
2) By Technology: PCR (​Polymerase Chain Reaction), MicroArrays, Genome Sequencing, Other Technologies
3) By Application: Diagnostics, Personalized Medicine, Drug Discovery And Development, Research
4) By End-User: Hospitals, Government Institutes, Research Facilities Subsegments:
1) By Instruments: Sequencers, PCR Machines, Microarrays, Other Diagnostic Instruments
2) By Consumables: Reagents And Kits, Sample Preparation Products, Nucleotides, Other Consumables
3) By Services: Data Analysis Services, Bioinformatics Services, Genetic Testing Services, Other Support ServicesFor further insights on the genomics in cancer care market,
request a sample here

Which region has the largest share of the genomics in cancer care market? What are the other regions covered in the report?

North America was the largest region in the genomics in cancer care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics in cancer care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the genomics in cancer care market, request a sample here.

Who are the major players in the genomics in cancer care market?

Major companies collaborate and get into partnerships to strengthen their position in the genomics in cancer care market. A business strategic partnership refers to a structured affiliation between two or more commercial enterprises, typically established via one or more business agreements or contracts. For instance, in June 2022, C2i Genomics, an Israel-based genomic cancer treatments company partnered with Karkinos Healthcare. The collaboration seeks to bring innovative cancer detection technology to drive R&D, future pharma partnerships and clinical use in India and supports the C2i Genomic’s long-term goals to scale pharma R&D projects around the globe. Karkinos Healthcare is an India-based technology led managed care platform for cancer. For further insights on the genomics in cancer care market, request a sample here.

What are the key trends in the genomics in cancer care market?

Major trend in the genomics in cancer care market - Transforming Cancer Care The Rise Of Robotic Genomic Testing Facilitie . For further insights on the genomics in cancer care market, request a sample here.

What are the major opportunities in the genomics in cancer care market? What are the strategies for the genomics in cancer care market?

For detailed insights on the major opportunities and strategies in the genomics in cancer care market, request a sample here.

How does the genomics in cancer care market relate to the overall economy and other similar markets?

For detailed insights on genomics in cancer care market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the genomics in cancer care industry?

For detailed insights on the mergers and acquisitions in the genomics in cancer care industry, request a sample here.

What are the key dynamics influencing the genomics in cancer care market growth? SWOT analysis of the genomics in cancer care market.

For detailed insights on the key dynamics influencing the genomics in cancer care market growth and SWOT analysis of the genomics in cancer care industry, request a sample here.